Latest Documents


  • 3-February-2015

    English

    Dementia Research and Care - Can Big Data Help?

    OECD countries are developing strategies to improve the quality of life of those affected by dementia and to support long-term efforts for a disease-modifying therapy or cure. The OECD jointly hosted an international workshop in Toronto with the Ontario Brain Institute (OBI) and the Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto on 14-15 September 2014. The aim of the workshop was to advance

  • 22-janvier-2015

    Français

    Personnels de santé

    Les personnels de santé sont essentiels pour assurer l'accès à des soins de qualité et rentables. Le travail de l'OCDE examine les tendances et les priorités en ce qui concerne les politiques en matière de personnels de santé dans les pays de l'OCDE.

    Also AvailableEgalement disponible(s)
  • 20-January-2015

    English

    Waiting Times

    Over the past decade, many OECD countries have introduced new policies to tackle excessive waiting times for elective treatments with some success. However, in the wake of the recent economic downturn and severe pressures on public budgets, waiting times may rise again, and it is important to understand which policies work.

  • 15-janvier-2015

    Français

    Encore trop de disparités régionales dans la qualité des soins de santé en Italie, selon une nouvelle étude de l’OCDE

    Au cours des dernières décennies, l’Italie a considérablement amélioré la qualité de ses soins de santé, mais elle doit encore réduire les fortes disparités régionales qui subsistent, selon une nouvelle étude de l’OCDE.

    Documents connexes
  • 16-December-2014

    English

    Paying providers for health care

    How health providers are paid is one of the key policy levers that countries have to drive health system performance. The 2012 HSC Survey analyses the payment modes currently in use in OECD countries to remunerate primary care, outpatient specialist care and inpatient care, the price regulations for health services and identifies new innovative modes of payments in more detail.

    Related Documents
  • 3-December-2014

    English, PDF, 236kb

    Health at a Glance: Europe 2014 - Briefing Note for Germany

    Progress has been made to reduce smoking rates and alcohol consumption in Germany, but obesity is on the rise as in most other EU countries. As in other EU countries, spending for prevention in Germany accounts only for around 3% of current health spending.

    Related Documents
  • 3-December-2014

    English, PDF, 306kb

    Health at a Glance: Europe 2014 - Briefing Note for Norway

    Excellent population health status and good outcomes associated with acute care reflect a high-performing health system in Norway. Norway’s good health system comes at a cost – Norway’s per capita health expenditure is the highest in Europe.

    Related Documents
  • 3-December-2014

    English

    Health at a Glance: Europe 2014

    This third edition of Health at a Glance: Europe presents a set of key indicators related to health status, determinants of health, health care resources and activities, quality of care, access to care, and health expenditure and financing in 35 European countries, including the 28 European Union member states, four candidate countries and three EFTA countries. The selection of indicators is based largely on the European Core

  • 3-December-2014

    English, PDF, 281kb

    Health at a Glance: Europe 2014 - Briefing Note for the United Kingdom

    The number of doctors in the UK has grown more rapidly than in any other EU countries since 2000; the number per capita remains lower than the EU average. There has been a sharp drop in deaths from heart attacks in the UK since 2000, reflecting reductions in important risk factors like smoking and better treatments.

    Related Documents
  • 3-December-2014

    English, PDF, 271kb

    Health at a Glance: Europe 2014 - Briefing Note for Ireland

    Despite cuts in recent years, health spending as a share of GDP in Ireland remains slightly higher than the EU average and pharmaceutical spending in particular remains relatively high.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 > >>